Norway· NO-ID_2DF7244B-7F73-4EBF-A593-511EBEE5C04A
Insulatard InnoLet
A insulin (human) product containing insulin + human, registered in Norway by Novo Nordisk. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Insulin (human) is registered in 11 of 19 countries.
Countries holding a registration under ATC A10AC01 (insulin (human)), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Insulin (human) · ATC A10AC01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Insulin + Human
- Manufacturer
- Novo Nordisk
- Country
- Norway (NO)
- ATC code
- A10AC01
- ATC class
- Insulin (human)
- Defined daily dose
- 40 E, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- gtin7046260139015
- no_merkevare_idID_2DF7244B-7F73-4EBF-A593-511EBEE5C04A
- no_varenummer2442545 x 3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
460 interactions on record for insulin (human).
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Insulin (human) · interactions on record
460 records
- 15 severe
- 395 moderate
- 50 minor
Most severe, free to view
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- PrednisoloneA07EA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A10AC01
Insulin (human), as other registers publish it.
- PolandGensulin NBioton S.A.
- PolandGensulin NBioton S.A.
- SwitzerlandHuminsulin Basal
- SwitzerlandHuminsulin Basal KwikPen
- IrelandHumulin I (Isophane) 100 IU/ml Suspension for Injection in cartridgeEli Lilly Nederland B.V.
- IrelandHumulin I (Isophane) 100 IU/ml Suspension for Injection in vialEli Lilly Nederland B.V.
- IrelandHumulin I KwikPen (Isophane) 100 IU/ml Suspension for InjectionEli Lilly Nederland B.V.
- PolandHumulin NEli Lilly Nederland B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe028b4e-81ba-4805-888f-e24dcc47e904 GET /v1/drugs/fe028b4e-81ba-4805-888f-e24dcc47e904?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, suspensjon",
"source": "fest",
"status": "A",
"atc_name": "Insulin, human",
"merkevare_id": "ID_2DF7244B-7F73-4EBF-A593-511EBEE5C04A",
"name_form_strength": "Insulatard InnoLet inj væske, susp 100 IE/ml",
"prescription_group": "C"
}See everything about insulin (human).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.